Xentria Seeks to Begin Clinical Trial of XTMAB-16
News
Xentria is seeking regulatory approval to begin clinical trials to test XTMAB-16, its investigational TNF-alpha inhibitor for the treatment of sarcoidosis. Xentria submitted the request — in the form of an investigational ... Read more